ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Affidea Romania Has Acquired Biomed Scan Clinics

By: Newsfile

Bucharest, Romania--(Newsfile Corp. - December 1, 2023) - Affidea Romania, the local subsidiary of the Affidea Group, a European leader in high-performance diagnostic imaging, outpatient services, and treatment, has acquired the Biomed Scan centers in the capital city, thereby reaching a total of 48 multidisciplinary clinics nationwide.

Affidea Romania's expansion plan, one of the most important providers of integrated medical services in the domestic market, continues with the acquisition of the two Biomed Scan medical centers - located in the Vitan-Dristor and Titan areas of Sector 3 in the capital.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/9716/189536_de114cc444e128a4_001.jpg

BIOMED SCAN Cardiologie RMN Ecografie

Biomed Scan offers patients state-of-the-art imaging services: MRI (4 latest generation devices, including one 3Tesla), all types of ultrasounds, as well as specialist consultations (Cardiology, Gastroenterology, Neurology).

"Affidea Romania continues its expansion both in the capital and nationally, working intensively to achieve the goal of facilitating access to integrated, quality medical services for as many Romanians as possible. The acquisition of Biomed Scan materializes our desire to be present in Sector 3 of the capital, serving important areas with a high concentration of residents," says Răzvan Predica, CEO of Affidea Romania and Hungary.

Affidea will invest in the development of the current portfolio of medical procedures in the two acquired centers, both in the area of specialist consultations and in the field of imaging investigations.

Annually, over 25,000 patients have undergone MRI investigations at Biomed Scan centers. Following the expansion of medical services, an even greater number of patients will have the opportunity to benefit from investigations both through CAS reimbursement and in the private medical system.

In this transaction, Affidea was legally assisted by the team of Rizoiu & Poenaru Law Firm, and the financial and tax due diligence services were performed by the DLA Piper Tax team, in collaboration with TS Partners.

Biomed Scan Clinic was represented by the team of lawyers of Rădulescu & Mușoi Law Firm.

About Affidea Romania

Affidea Romania is a major provider of medical services in our country, part of a European group, having up to the acquisition of Biomed Scan 46 clinics in 26 cities. Under the umbrella of Affidea Romania are also present the clinics Hiperdia, Sanmed, Phoenix, Medsan, as well as ExMed.

The Affidea Romania team consists of 1,500 professionals, over 900 clinicians, treating approximately 2 million patients annually.

About the Affidea Group

Affidea is the largest European provider of advanced diagnostic imaging, outpatient, and cancer treatment services. Founded in 1991, the company operates over 330 centers in 15 countries, providing high-quality medical services to 12 million patients each year.

Due to its special attention to patient safety, Affidea is the most awarded provider of medical imaging services in Europe, last year winning the Diagnostic Provider of the Year award at the HealthInvestor Awards 2022. Over 90% of the centers awarded 5 stars Eurosafe by the European Society of Radiology are Affidea centers.

BIOMED SCAN Cardiologie RMN Ecografie
Strada Răcari 6A, București 031827
https://biomedscan.ro/
office@biomedscan.ro
+40219967

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/189536

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.